CONTRAFECT Corp (27) | Development Agreements (2)
- Amendment of Solicitation/Modification of Contract between the Biomedical Advanced Research and Development Authority and ContraFect Corporation, dated August 24, 2022 (Filed With SEC on November 14, 2022)
- Cost-Sharing Agreement by and between ContraFect Corporation and the BioMedical Advanced Research and Development Authority, dated March 10, 2021 (Filed With SEC on March 12, 2021)
